Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

10.21
Delayed Data
As of Mar 27
 -0.09 / -0.87%
Today’s Change
4.07
Today|||52-Week Range
12.88
+8.73%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 15.50, with a high estimate of 20.00 and a low estimate of 11.00. The median estimate represents a +51.81% increase from the last price of 10.21.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.18
Sales
$49.8M
Reporting Date
May 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.75%
 
 
 
 
 
 
Growthannually 30.11%
 
 
 
 
 
 

Sales

Growthquarterly -7.56%
 
 
 
 
 
 
Growthannually 93.64%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account